LATE BREAKING ABSTRACTS
ABSTRACT DOWLOADS
Before submitting your abstract, please ensure you read the abstract guidelines and use the appropriate template below:
Late Breaking Abstract Guidelines
Research Abstract Template – Oral / Poster
Practice Based /Service Delivery Abstract Template – Oral / Poster
Late Breaking Abstract
Late Breakers are informative, fast-paced 5-minute presentations. The sessions are dedicated to new information or important findings not fully available before the general abstract deadline. Presentations are five minutes and should have no more than five slides.
Late Breaking presentations are held in a single stream, providing an opportunity to present to all conference delegates, including Virtual attendees. Late Breakers are a popular session with delegates at the conference.
Late Breaking Abstract Deadline: 11:59 (ACST) Monday 14 August 2023
Please note that the Late Breaking Abstract deadline is not an extension of the general abstract submission deadline.
In order to standardise the abstract layout, we kindly ask you to read the abstract submission guidelines carefully and use the appropriate abstract template provided.
Notification regarding late breaking abstract’s status (accepted or rejected) will be sent to the presenting author of the abstract by Wednesday 20 September 2023.
Abstracts will be accepted for oral and poster Late Breaking presentations.
Late Breaking Prize
APSAD has a prize for best Late Breaking Presentation delivered at the Conference. The presenter judged as preparing and delivering the Best Late Breaking Presentation receives a certificate and a book voucher valued at $150. The award will be announced at the closing session of the conference.
There will also be certificates for the runner up and an honourable.
The Late Breaking Presentations are judged on the basis of original scientific importance or clinical or policy relevance, and clarity of presentation.
Late Breaking Abstract Submission Instructions
Presentation Types
The Scientific Advisory Committee welcomes the submission of Late Breaking abstracts for presentation at the APSAD Adelaide 2023 Hybrid Conference for the following formats;
| FORMAT | TYPE | LENGTH | DESCRIPTION | TEMPLATE | |
|---|---|---|---|---|---|
| ORAL PRESENTATION | Research Abstract | 5 minutes x 5 slides | Abstracts on original research findings, case studies, completed projects and policy or theoretical analyses. Presentations should be well structured, rigorous and demonstrate a novel contribution to knowledge. | Research Template | |
| ORAL PRESENTATION | Practice Based /Service Delivery Abstract | 5 minutes x 5 slides | Abstracts analysing issues and solutions to problems in clinical practice, policy, community engagement, education, and health promotion. Presentations should be well structured, rigorous and demonstrate a novel contribution to knowledge. This option allows you to report on projects that are not research-driven but are critical reflections on policy and practice, including clinical practice, community engagement, education, health promotion, and service delivery. In all cases we are looking for analyses and projects that are completed and have concrete results to report. The practice-based abstract template asks delegates to describe the analysis and arguments used, and then specify outcomes, results and implications for policy and practice. We encourage our community, nursing, policy, health promotion and other colleagues to try the template and submit abstracts. | Practice Based / Service Delivery Template | |
| VISUAL PRESENTATIONS | Poster Abstract | Permanently displayed during the conference. Presenters must stand with their posters during the dedicated Poster Sessions. | Posters are a key component of the APSAD Conference offering an interactive platform for delegates to view and discuss achievements, ideas, and developments face-to-face. Posters are ideal for data that works better visually, projects and research being proposed or currently in progress, systematic reviews, meta-analyses, case studies, divisional projects, or clinical topics. | As appropriate to the topic and approach; Practice Based / Service Delivery Template or Research Template |
|
The Late Breaking session is dedicated to late-breaking and unpublished findings and cannot be a revision of an abstract submitted during the general abstract submission process. Late Breaking abstracts, containing new information or important findings not (fully) available before the general abstract deadline, can be submitted. For abstract preparation guidelines please see the abstract guidelines.
Please note that the Late Breaking abstract deadline is not an extension of the general abstract submission deadline.
Abstracts must be submitted by 11:59 (ACST) Monday 14 August 2023, there will be no extension to the submission closing date.
Abstract Templates
Abstracts must be submitted using the appropriate abstract template, please see the template options below;
Please read the abstract guidelines carefully. Any abstracts that do not conform to the guidelines will not be considered.
The Scientific Advisory Committee may reallocate a presentation type based on time, content, space available and applicability to the Conference themes.
| SERVICE DELIVERY / PRACTICE BASED | RESEARCH | |
|---|---|---|
| For: | Service & program delivery, i.e., alcohol and drug services, clinical health services, community health, peer-based services, policy, and prevention | Quantitative, qualitative, mixed methods research, policy, or theoretical analyses |
| 1 | Background: Provide a clear description of the rationale for the program, the aims you set out to achieve in the program, service, or initiative. | Introduction /Issues: Provide a description of the issue or problem being addressed, the rationale for the study, and the objectives /research questions. |
| 2 | Description of Model of Care / Intervention: What are the key points that came out of your program /service /initiative? What method of evaluation /approach did you use and why did you decide to use this method? | Method / Approach: Clearly describe the design and method(s) or approach you used, e.g. What was the study population or data source? What were the data collection methods used? What method of analysis did you use? |
| 3 | Effectiveness: What is the main outcome /impact of the program /project? Are there any new outcomes, or are existing outcomes reinforced? Acceptability: How was the program received by the participants? Implementation: Has the program /service /initiative continued? Are there any follow up programs or projects? What is the main outcome of the program /project? | Key Findings /Results: Clearly summarise the results. Your abstract must include data (e.g., statistics or qualitative data). For quantitative findings, include the outcomes and results of relevant statistical tests such as p values, odds or hazard ratios and confidence intervals. |
| 4 | Conclusion and Next Steps: Has the program /service /initiative continued? Are there any follow up programs or projects? What is the main outcome of the program /project? How did it contribute to evidence-based practice /knowledge /better outcomes for the participants? | Discussion and Conclusions: Provide your interpretation of the data. What are the main outcomes and implications of the study? Highlight novel findings or failings, it is equally important to hear about what has not worked and why. |
| 5 | Implications for Practice or Policy: What is the implication for, and contribution to, evidence-based practice or policy? | Implications for Practice or Policy: What is the implication for, and contribution to, evidence-based practice or policy? |
Note: Abstract presenters will be required to fund their own attendance at the conference and should not submit an abstract if this is not possible.
Disclosure of Interest/Ethical Statement
APSAD recognises the considerable contribution that industry partners make to professional and research activities. We also recognise the need for transparency of disclosure of potential conflicts of interest by acknowledging these relationships in publications and presentations.
For an example of a disclosure of interest/ethical statement please see below
Dr Smith has received funding from Metabolism Corp. No pharmaceutical grants were received in the development of this study.
If accepted into the program you will be requested to include a disclosure of interest slide into your presentation or include such statements in your poster..
Selection Criteria
Abstracts will be favoured at review if they incorporate:
- Completed rather than future work (i.e., final results),
- Original data of high quality,
- An analysis that extends existing knowledge,
- Clarity of methodology, analysis and presentation of results,
- Specific rather than general findings.
- Late-breaking submissions must be truly late-breaking, meaning the material was not available for submission by the regular deadline of 5 June 2023
In balancing the program, the committee may require authors to present their work in an alternate format (e.g., as a poster rather than oral presentation).
IMPORTANT: We encourage abstracts that are based on First Nations issues be presented by First Peoples, or a First Nations co-presenter be included. If this is not possible, please include information as to whether any member of the First Nations community in which the research is based was involved in development of the research protocol or in conducting the research. Where possible this applies to other population groups as well.
Themes for Submission
Authors must select one primary and one secondary theme of the following that their abstract relates to.
| Addiction reconceptualised | Injecting drug use |
|---|---|
| Adolescents / youth | Innovative prescribing: medicinal cannabis, e-cigs, etc. |
| Aetiology (incl. genetics) | LGBTIQ+ |
| Aged care / aging population / 65+ | Methamphetamine & psychostimulants |
| Alcohol | Neuroscience |
| Blood-borne viruses (incl. STI) | New technologies & e-interventions |
| Cannabis | Older adults |
| Children & families | Other AOD issues |
| Coercive treatment | Overdose |
| Cognitive impairment training | Peer workforce / stigma in the field |
| Comorbidity | People with lived experience – people who use drugs /services, etc |
| Covid-19 | Perinatal /1st 1000 days /maternal issues /family |
| Crime, justice, & legal issues | Pharmaceuticals (consumption) |
| Cross culture & international | Prescription opioid treatment |
| Disability / NDIS | Prevention & early intervention |
| Drug monitoring / novel psychoactive | Primary care - pharmacy in primary care |
| Drug policy reform | Prisons & prisoner health |
| Ecstasy & emerging psychoactive substances | Psychopharmacology & psychobiology |
| eHealth – behavioural change | Regional challenges & innovations |
| Epidemiology | Social & community issues |
| FASD | Special populations |
| First Peoples | Tobacco & tobacco /nicotine cessation |
| Gambling | Translating research into practice - different perspectives from researchers, lived experience, clinicians etc |
| Harms & harm reduction | Treatment & interventions |
| Health policy & reforms | Treatment settings |
| Health services & systems | Well at work |
| Health, law & human rights | Women |
| Heroin & opioids | Workforce issues |
Notification of Acceptance
Notifications of acceptance will be sent via e-mail to the submitting author by Wednesday 20 September 2023.